World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
52563
World Ranking
8137
National Ranking
268

Robin Foà publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robin Foà sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,085 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robin Foà D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robin Foà sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Robin Foà is affiliated with Sapienza University of Rome in Italy and has contributed extensively to medical research, particularly within hematology and oncology fields. Their work is concentrated on various leukemias, including chronic lymphocytic leukemia and acute lymphoblastic leukemia, encompassing research on diagnosis, treatment, and clinical outcomes.

The research topics covered in their publications include:

  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Immunodeficiency and Autoimmune Disorders
  • CAR-T cell therapy research

Their main fields of study fall under Medicine, with notable focus on subfields such as Genetics, Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, and Oncology. This interdisciplinary approach reflects their involvement in both clinical and translational research.

Frequent publication venues for their work include:

  • Blood
  • HemaSphere
  • Haematologica
  • British Journal of Haematology
  • Hematological Oncology

Notable coauthors who have collaborated with Robin Foà on multiple occasions include Sabina Chiaretti, Antonio Cuneo, Francesca Romana Mauro, Gianluca Gaïdano, and Ilaria Del Giudice, indicating a network of researchers within hematologic malignancies and related medical disciplines.

Among Robin Foà's significant publications are:

  • Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults (2020), published in New England Journal of Medicine
  • Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL (2023), published in Journal of Clinical Oncology

These papers reflect contributions to understanding treatment regimens for Philadelphia chromosome-positive acute lymphoblastic leukemia, a subset of leukemia with specific genetic characteristics.

Best Publications

  • A mammalian microRNA expression atlas based on small RNA library sequencing.

    Pablo Landgraf;Mirabela Rusu;Robert Sheridan;Alain Sewer;Alain Sewer

  • Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

    Meletios Dimopoulos;Andrew Spencer;Michael Attal;H. Miles Prince

  • Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

    Hagop M Kantarjian;Anthony Stein;Nicola Gökbuget;Adele K. Fielding

  • Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

    Max S. Topp;Nicola Gökbuget;Anthony S. Stein;Gerhard Zugmaier

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group

    Torsten Haferlach;Alexander Kohlmann;Lothar Wieczorek;Giuseppe Basso

  • Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

    Giulia Fabbri;Silvia Rasi;Davide Rossi;Vladimir A. Trifonov

  • Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

    Giampaolo Bucaneve;Alessandra Micozzi;Francesco Menichetti;Pietro Martino

  • Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.

    Valerio Fulci;Sabina Chiaretti;Marina Goldoni;Gianluca Azzalin

  • Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

    Ramiro Garzon;Michela Garofalo;Maria Paola Martelli;Roger Briesewitz

  • Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Valeria Spina;Alessio Bruscaggin

  • ATM-ATR–dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

    Alessandra Soriani;Alessandra Zingoni;Cristina Cerboni;Maria Luisa Iannitto

  • Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

    Davide Rossi;Silvia Rasi;Giulia Fabbri;Valeria Spina

  • Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

    Gilles Salles;Martin Barrett;Robin Foà;Joerg Maurer

  • Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia

    Bradley T. Messmer;Emilia Albesiano;Dimitar G. Efremov;Fabio Ghiotto;Fabio Ghiotto

  • Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival

    Sabina Chiaretti;Xiaochun Li;Xiaochun Li;Robert Gentleman;Robert Gentleman;Antonella Vitale;Antonella Vitale

  • Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    Robin Foà;Antonella Vitale;Marco Vignetti;Giovanna Meloni

  • Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

    Davide Rossi;Alessio Bruscaggin;Valeria Spina;Silvia Rasi

  • Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

    Marco Vignetti;Paola Fazi;Giuseppe Cimino;Giovanni Martinelli

  • Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

    Elisabetta Flex;Valentina Petrangeli;Lorenzo Stella;Sabina Chiaretti

Frequent Co-Authors

Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Davide Rossi
Davide Rossi European Society for Medical Oncology
Luca Laurenti
Luca Laurenti Catholic University of the Sacred Heart
Francesco Di Raimondo
Francesco Di Raimondo University of Catania
Giovanni Martinelli
Giovanni Martinelli University of Bologna
Franco Mandelli
Franco Mandelli Sapienza University of Rome
Valter Gattei
Valter Gattei University of Trieste
Maria Teresa Petrucci
Maria Teresa Petrucci Sapienza University of Rome
Michele Baccarani
Michele Baccarani University of Bologna
Giuseppe Saglio
Giuseppe Saglio University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine can open doors to many related degree options and advanced healthcare pathways. For those interested in healthcare leadership, the cahme accredited online mha programs list offers guidance on top online Master of Healthcare Administration programs with industry accreditation, ideal for students seeking flexible, high-quality management education.

Registered nurses hoping to advance quickly may benefit from rn to bsn online no clinicals accredited programs. These allow RNs to complete their Bachelor of Science in Nursing entirely online without clinical requirements, making it a convenient option for working professionals.

Nurses aspiring to reach the highest clinical ranks might consider a Doctor of Nursing Practice (DNP). For a faster route, explore the fastest dnp online program options, which highlight accelerated paths to a doctoral degree. If finding a manageable program is a priority, the dnp programs list showcases programs recognized for their accessibility and student support.

By leveraging these online learning opportunities, students and professionals can broaden their career prospects and achieve advanced roles within the medical field.

Best Scientists Citing Robin Foà

Trending Scientists

Recently Published Articles